First Cited
Last Cited

Articles citing This Document (Page 1 of 1)

Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications2022
Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claimJournal of Cannabis Research2022
Management of Toxicological Emergencies in the School Setting: An Overview for School Nurses Part 2NASN School Nurse (Print)
Recent advances in drug delivery to the central nervous system by inhalation.Expert Opinion on Drug Delivery2022
The Effects of Cannabinoids on Sleep.Journal of Primary Care and Community Health2022
Evaluation of the impact of a clinical pharmacist on a specialty neurology clinic's adherence to recommended laboratory test monitoringJournal of Managed Care & Specialty Pharmacy2021
Cannabis in Palliative Medicine2020
Cannabinoids and Mental Health, Part 2: The Search for Clinical ApplicationsJournal of Psychosocial Nursing and Mental Health Services2019
Post Marketing Safety of Plus CBD™ Products, a Full Spectrum Hemp Extract: A 2-Year ExperienceJournal of Dietary Supplements2020
Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future StrategiesCNS Drugs2021
Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MSClinical Biochemistry2021
A Review of the Selected and Newer Antiseizure Medications Used in Childhood EpilepsiesIndian Journal of Pediatrics2021
Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional studyJournal of Cosmetic Dermatology2021
Impact of pre-operative recreational marijuana use on outcomes two years after orthopaedic surgeryInternational Orthopaedics2021
Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut SyndromeCNS Drugs2021
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trialsActa Neurologica Scandinavica2021
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndromeExpert Review of Neurotherapeutics2021
Use of Herbal Medicine by Pregnant Women: What Physicians Need to KnowFrontiers in Pharmacology2019
Disposition of Oral Cannabidiol-Rich Cannabis Extracts in Children with EpilepsyClinical Pharmacokinetics2020
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic PainJournal of Pain Research2020
Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acidEpilepsia2020
Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic ReviewDrugs in R and D2020
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical ImplicationsCNS Drugs2020
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trialsEpilepsia2020
The effect of cannabidiol on the pharmacokinetics of carbamazepine in ratsNaunyn-Schmiedeberg's Archives of Pharmacology2020
Safety Considerations in Cannabinoid-Based MedicineInternational Journal of General Medicine2020
Therapeutic advances in Dravet syndrome: a targeted literature reviewExpert Review of Neurotherapeutics2020
Beyond Green Chemistry: Teaching Social Justice in Organic ChemistryJournal of Chemical Education2020
A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case reportJournal of Medical Case Reports2020
The Essential Medicinal Chemistry of Cannabidiol (CBD)Journal of Medicinal Chemistry2020
Report of a 6-month-old Asian infant with early infantile epileptic encephalopathy whose seizures were eliminated by cannabidiolEpilepsy and Behavior Reports2020
Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label StudyFrontiers in Neurology2020
Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug InteractionJournal of Pharmacy Practice2020
Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and GapsFrontiers in Neurology2020
Buprenorphine-cannabis interaction in patients undergoing opioid maintenance therapyEuropean Archives of Psychiatry and Clinical Neuroscience2021
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional surveyBMC Family Practice2019
Medicinal use of cannabis based products and cannabinoidsBMJ, The2019
A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic ImpairmentJournal of Clinical Pharmacology2019
An Update of Current Cannabis-Based Pharmaceuticals in Pain MedicinePain and Therapy2019
Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic ReviewAlcoholism: Clinical and Experimental Research2019
[Cannabis-derived medicines for the treatment of chronic pain : Problems resulting from medical appraisals in the experience of the Medical Advisory Board of the Statutory Health Insurance Funds North]Schmerz2019
Stiripentol: A Review in Dravet SyndromeDrugs2019
[Survey of neurologists regarding their attitudes toward medicinal cannabis and the effects of evidence-based cannabis education]Clinical Neurology2019
Cannabis and Cannabinoids: Kinetics and InteractionsAmerican Journal of Medicine2019
Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizuresExpert Review of Neurotherapeutics2019
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-AnalysisDrugs2018